Sharoni Billik is a seasoned pharmaceutical professional with over 20 years of experience in the industry. In 2016, she founded Sharoni Billik Healthcare Communications (SBHC), a company dedicated to providing global biopharmaceutical clients with tailored solutions for advisory boards, investigator meetings, consensus-building (Delphi-panel) meetings, publication planning, KOL identification/engagement, and congress planning in clinical, medical affairs, and commercial.
Sharoni is passionate about creating effective and streamlined processes that meet the unique needs of each client.
Sharoni received her BS in physiology & neuroscience from the University of California San Diego (UCSD), a Masters of Bioscience from the Keck Graduate Institute (Claremont Colleges), and an MBA from the Peter F. Drucker Graduate School of Management. Her expertise lies in working with small- and medium-sized biopharmaceutical companies in early to late phase 2 as they start to plan their strategy with investigators and KOLs.
Sharoni’s commitment to excellence has been recognized by industry peers, as she was named the Best Medical Affairs Professional Service Provider in California by Global Health & Pharma in 2019. In 2022, she was invited to speak at Fierce Pharma’s Pharma Meeting Professionals Summit.
With her vast experience and dedication to her clients, Sharoni is a sought-after advisor for biopharmaceutical companies looking to build relationships with investigators and KOLs, and to ensure the success of their clinical programs.